Tumor Microenvironment (Immune Activation) (TME (Immune Activation))

The tumor microenvironment (TME) refers to the complex milieu surrounding tumor cells, including various immune cells, stromal cells, blood vessels, signaling molecules, and extracellular matrix components. Immune activation within the TME is a critical determinant of cancer progression or regression. The balance between immune-activating and immunosuppressive factors in this environment shapes the outcome of anti-tumor immunity. Active immune responses in the TME are characterized by infiltration of effector immune cells such as CD8+ cytotoxic lymphocytes and secretion of pro-inflammatory cytokines. Tumors often develop mechanisms to evade or suppress local immune activation, such as recruitment of regulatory T-cells and expression of inhibitory molecules like PD-L1. Strategies aimed at enhancing immune activation in the TME include blocking immunosuppressive pathways and promoting recruitment/activation of effector immune populations.

Other names

TME immune responseAnti-tumor immunityTumor immune contexture

Varies depending on the specific therapeutic agent. Examples include blocking immune checkpoints, stimulating effector immune cell activity, and inhibiting immunosuppressive factors.